Are commercial conflicts of interests justifiable in medical journals?

June 3, 2015
Credit: Charles Rondeau/public domain

A group of former senior editors, writing in The BMJ today, criticise a "seriously flawed and inflammatory attack" by The New England Journal of Medicine (NEJM) on what that journal believes have become overly stringent policies on conflicts of interest.

The NEJM was the first major medical journal to introduce policies in 1984. It required all authors to disclose any financial ties to health industries and made conflict of interests more transparent.

But recently the NEJM published a series of commentaries and an editorial that attempt to justify and rationalise financial conflicts of interests in medicine, and assert that there are negative consequences of such policies.

The articles by national correspondent, Lisa Rosenbaum, and supported by editor in chief, Jeffrey Drazen, "reinterpret and downplay the importance of in medicine" and do not provide evidence to back claims, argue former senior editors from the NEJM.

They explain that the key concerns for medical journals are not about doctors and researchers being bought by drug companies, or being motivated by a desire for financial gain.

Rather the essential issue is that the objectivity of authors with financial conflicts of interest "might be compromised, either consciously or unconsciously and there would be no easy way to know whether it had been."

They explain that judges and journalists, for example, are expected to stay away from cases or stories in which they have a financial conflict of interest.

"Yet Rosenbaum and Drazen seem to think it is insulting to physicians and medical researchers to suggest that their judgment can be affected in the same way," they add.

The authors acknowledge that doctors and researchers sometimes have with industry for research and consulting specifically related to research, but argue that physicians who develop products and hold patents or receive royalties should not evaluate the products they develop.

Financial conflicts of interest have eroded the credibility of the medical profession, and doctors and the public expect journals to be trustworthy, they explain.

In addition, they commend The BMJ's introduction of a "zero tolerance" policy on educational articles by authors with any industry ties.

In an accompanying editorial, a group of senior editors at The BMJ also respond to NEJM's articles, saying that they are "deeply troubled by a possible retreat from policies that prevent experts with relevant commercial ties from authoring commentary or review articles."

Such policies were not motivated by a few events, as Drazen suggests, but by recognition of extensive, systemic problems, they add, and argue for a separation between doctors working with industry to develop treatments and those who can assess medical evidence without any conflict of interest.

While they agree that experts with industry funding may be able to express independent views, journal readers and editors do not have a reliable way to see which thoughts might be influenced. "Bias is not always overt or easily detected," they explain.

They conclude: "It is a mistake by NEJM to suggest that rigorous standards should be revisited. To do so would undermine the trustworthiness of and be a disservice to clinical practice and patient safety."

Explore further: Disclosure of financial conflicts of interest may worsen medical bias

More information: Justifying Conflicts of Interest in Medical Journals: A Very Bad Idea, The BMJ, www.bmj.com/cgi/doi/10.1136/bmj.h2942

Revisiting the Commercial-Academic Interface in Medical Journals, The BMJ, www.bmj.com/cgi/doi/10.1136/bmj.h2957

Related Stories

Disclosure of financial conflicts of interest may worsen medical bias

April 24, 2012
"Journals, professional associations, clinical guideline developers, and others need to worry not just that disclosure provides a band-aid to the real problem of the [conflict of interest] itself, but that any attempt to ...

Physicians are biased when evaluating medical conflict of interest policies

June 19, 2012
Medical institutions have been under pressure to develop and implement policies to avoid conflicts of interest between physicians and pharmaceutical companies. In most cases, medical professionals who have a stake in the ...

Conflicts of interest plague the next international manual of mental disorders

March 13, 2012
There are concerns that the revised Diagnostic and Statistical Manual of Mental Disorders (DSM—an internationally recognised classification of mental disorders produced by the American Psychiatric Association), scheduled ...

Authors with financial conflicts reporting negative outcomes in major orthopaedic journals

February 10, 2012
In a new study presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers completed a systematic review of three major orthopaedic journals – the Journal of Bone and ...

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.